A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)
Clinical trial NCT07121959 · COMPLETED
Trial details
- NCT number
- NCT07121959
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2025-09-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.